Strategic Growth NCODA is expanding its executive leadership with four new Executive Council members in February 2026, signaling a focus on governance, strategic partnerships, and broader influence in oncology care. This presents a sales opportunity to align with their expanded leadership during product or service evaluations and to offer solutions that support nationwide collaboration and governance initiatives.

Global Outreach With the launch of the Global Oncology & Haematology Congress in March 2026 and ongoing international engagement, NCODA is pursuing global collaboration and education. This creates potential for scalable international solutions, conference sponsorships, and cross-border data or analytics tools that support multicountry oncology programs.

Data Enabled NCODA operates Oncology Insights Program and leverages prescriber data through MiBA, indicating a strong emphasis on data analytics, insights, and evidence-based collaboration. This suggests opportunities to offer advanced analytics platforms, data integration services, and targeted outreach tools that enhance prescriber insights and patient care optimization.

Digital Foundations A tech stack featuring AWS, WordPress, marketing platforms, DocuSign, and analytics indicates mature digital infrastructure and a reliance on cloud, engagement, and e-signature workflows. This presents opportunities to propose scalable cloud-based services, secure digital workflows, CRM/marketing automation enhancements, and integrated patient engagement solutions.

Financial Footing With reported revenue in the 10 to 25 million USD range and an active nonprofit-style governance ecosystem, NCODA appears financially stable and investment-ready for partnerships or pilots. This creates openings for multi-year collaboration projects, sponsored programs, or value-based solutions that align with their mission of improving quality, safety, and access in oncology care.